Scott McMeekin
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Intraperitoneal and Appendiceal Malignancies, Uterine Myomas and Treatments, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer(2007)438 cited
- → Extraovarian Peritoneal Serous Papillary Carcinoma: A Case-Control Retrospective Comparison to Papillary Adenocarcinoma of the Ovary(1993)266 cited
- → MICU1 drives glycolysis and chemoresistance in ovarian cancer(2017)170 cited
- → Surgical Management of Early-Stage Endometrial Cancer in the Elderly: Is Laparoscopy Feasible?(2001)157 cited
- → Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma(2014)118 cited
- → Characteristics of 10-year survivors of high-grade serous ovarian carcinoma(2016)108 cited
- → A phase II trial of the mTOR inhibitor AP23573 as a single agent in advanced endometrial cancer(2007)100 cited
- → Laparoscopic Pelvic and Paraaortic Lymph Node Dissection: Analysis of the First 100 Cases(2001)99 cited
- → Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer(2016)96 cited
- → Exosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment(2015)93 cited